Skip to main content
Normal View

Medicinal Products Licensing

Dáil Éireann Debate, Wednesday - 27 September 2017

Wednesday, 27 September 2017

Questions (145)

Róisín Shortall

Question:

145. Deputy Róisín Shortall asked the Minister for Health further to Parliamentary Question No. 535 of 20 September 2017, if his attention has been drawn to the impact that the changes of the prescribing of Lidocaine have had on persons with fibromyalgia; if the HSE medicines management programme has investigated the impact that changes to the prescription of pain medication has on persons with fibromyalgia; and if he will make a statement on the matter. [40839/17]

View answer

Written answers

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for the administration of the community drug schemes; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

Top
Share